Dendritic Cell Vaccination With Standard Postoperative Chemoradiation for the Treatment of Adult Glioblastoma
Clinical trial NCT04552886 · COMPLETED
Trial details
- NCT number
- NCT04552886
- Sponsor
- The Cooper Health System
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-11
- Primary completion
- 2023-12-01
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.